Neuroleptics or antipsychotic agents
Dresse, A.
Revue Medicale de Liege 51(1): 65-69
1996
ISSN/ISBN: 0370-629X PMID: 8701140 Document Number: 466440
Document emailed within 1 workday
Related Documents
Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103Ginestet, D. 1998: Re-evaluating neuroleptics: their antipsychotic properties? Presse Medicale 27(40): 2164-2169
Nightengale, B.S.; Crumly, J.M.; Liao, J.; Lawrence, B.J.; Jacobs, E.W. 1998: Economic outcomes of antipsychotic agents in a Medicaid population: traditional agents vs. risperidone Psychopharmacology Bulletin 34(3): 373-382
Gosselin, O.; Di Scala, G.; Ribeyre, J.M.; Kahn, J.P. 1996: New antipsychotic agents: new paths of research on the notion of atypical agents L'Encephale 22(Special Issue 6): 3-6
Mehlum, L. 1992: Death caused by antidepressive agents and neuroleptics Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(10): 1336-1337
Rimón, R.; Leinonen, E. 2002: Should the second generation antipsychotic agents be used as drugs of choice? Duodecim; Laaketieteellinen Aikakauskirja 118(6): 585-590
Casey, D.E. 1996: Side effect profiles of new antipsychotic agents Journal of Clinical Psychiatry 57(Suppl): 40-45; Discussion 46-52
Waehrens, J. 1982: Convulsions during simultaneous treatment with neuroleptics and antidepressive agents Ugeskrift for Laeger 144(2): 106-108
Lehtonen, J.; Tacke, U. 2003: Difficult choice between various antipsychotic agents--should we broaden our view? Duodecim; Laaketieteellinen Aikakauskirja 119(12): 1159-1162
Omori, T. 2001: Efficacy of atypical antipsychotic agents for maintenance therapy of schizophrenia Seishin Shinkeigaku Zasshi 103(6): 470-475
Gram, L.F. 2000: Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine Ugeskrift for Laeger 162(13): 1914-1915
Roth, B.L.; Ciaranello, R.D.; Meltzer, H.Y. 1992: Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors Journal of Pharmacology and Experimental Therapeutics 260(3): 1361-1365
Moen, A.; Sørheim, S.; Brun, H.; Handal, M.; Helgheim, A.; Teige, B.; Wethe, G. 1992: Deaths caused by antidepressive agents and neuroleptics. Risk groups illustrated by a forensic material Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(5): 612-615
Sedvall, G.; Nybäck, H. 1973: Effect of clozapine and some other antipsychotic agents on synthesis and turnover of dopamine formed from 14C-tyrosine in mouse brain Israel Journal of Medical Sciences 9 Suppl: 24-30
Glaser, B.A.; Morreau, L.E. 1986: Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally retarded persons American Journal of Mental Deficiency 90(4): 371-379
Hertrich, O. 1983: Ataractic treatment in psychiatry and general medicine. Neuroleptics and thymoleptics. 3.1 Neuroleptics Fortschritte der Medizin 101(40): 1823; 1826-1827
Roth, B.L.; Craigo, S.C.; Choudhary, M.S.; Uluer, A.; Monsma, F.J.; Shen, Y.; Meltzer, H.Y.; Sibley, D.R. 1994: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors Journal of Pharmacology and Experimental Therapeutics 268(3): 1403-1410
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Dufresne, R.L.; Wagner, R.L. 1988: Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia Journal of Clinical Psychiatry 49(11): 435-438
Rise, A. 1976: Neuroleptics Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 96(7): 446-447